These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28407694)

  • 1. Molecular mechanisms of activating c-MET in KSHV+ primary effusion lymphoma.
    Lam BQ; Dai L; Li L; Qiao J; Lin Z; Qin Z
    Oncotarget; 2017 Mar; 8(11):18373-18380. PubMed ID: 28407694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
    Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
    J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kaposi's Sarcoma-Associated Herpesvirus Drives a Super-Enhancer-Mediated Survival Gene Expression Program in Primary Effusion Lymphoma.
    Manzano M; Günther T; Ju H; Nicholas J; Bartom ET; Grundhoff A; Gottwein E
    mBio; 2020 Aug; 11(4):. PubMed ID: 32843547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sangivamycin induces apoptosis by suppressing Erk signaling in primary effusion lymphoma cells.
    Wakao K; Watanabe T; Takadama T; Ui S; Shigemi Z; Kagawa H; Higashi C; Ohga R; Taira T; Fujimuro M
    Biochem Biophys Res Commun; 2014 Feb; 444(2):135-40. PubMed ID: 24434142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression Ratios of the Antiapoptotic BCL2 Family Members Dictate the Selective Addiction of Kaposi's Sarcoma-Associated Herpesvirus-Transformed Primary Effusion Lymphoma Cell Lines to MCL1.
    Dunham D; Viswanathan P; Gill J; Manzano M
    J Virol; 2022 Dec; 96(23):e0136022. PubMed ID: 36416587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrrolidinium fullerene induces apoptosis by activation of procaspase-9 via suppression of Akt in primary effusion lymphoma.
    Watanabe T; Nakamura S; Ono T; Ui S; Yagi S; Kagawa H; Watanabe H; Ohe T; Mashino T; Fujimuro M
    Biochem Biophys Res Commun; 2014 Aug; 451(1):93-100. PubMed ID: 25063029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis.
    Chandrasekharan JA; Huang XM; Hwang AC; Sharma-Walia N
    J Virol; 2016 Dec; 90(24):11020-11031. PubMed ID: 27681120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next-Generation Sequencing Analysis Reveals Differential Expression Profiles of MiRNA-mRNA Target Pairs in KSHV-Infected Cells.
    Viollet C; Davis DA; Reczko M; Ziegelbauer JM; Pezzella F; Ragoussis J; Yarchoan R
    PLoS One; 2015; 10(5):e0126439. PubMed ID: 25942495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cdk1 inhibition induces mutually inhibitory apoptosis and reactivation of Kaposi's sarcoma-associated herpesvirus.
    Li X; Chen S; Sun R
    J Virol; 2012 Jun; 86(12):6668-76. PubMed ID: 22496227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arctigenin induces the apoptosis of primary effusion lymphoma cells under conditions of glucose deprivation.
    Baba Y; Shigemi Z; Hara N; Moriguchi M; Ikeda M; Watanabe T; Fujimuro M
    Int J Oncol; 2018 Feb; 52(2):505-517. PubMed ID: 29207179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding pathogenetic aspects and clinical presentation of primary effusion lymphoma through its derived cell lines.
    Carbone A; Cesarman E; Gloghini A; Drexler HG
    AIDS; 2010 Feb; 24(4):479-90. PubMed ID: 20051807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic analysis of xCT-mediated regulatory network: Identification of novel targets against AIDS-associated lymphoma.
    Dai L; Cao Y; Chen Y; Kaleeba JA; Zabaleta J; Qin Z
    Oncotarget; 2015 May; 6(14):12710-22. PubMed ID: 25860939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ribonucleotide reductase represents a novel therapeutic target in primary effusion lymphoma.
    Dai L; Lin Z; Qiao J; Chen Y; Flemington EK; Qin Z
    Oncogene; 2017 Aug; 36(35):5068-5074. PubMed ID: 28459467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ER stress on unfolded protein responses, cell survival, and viral replication in primary effusion lymphoma.
    Shigemi Z; Baba Y; Hara N; Matsuhiro J; Kagawa H; Watanabe T; Fujimuro M
    Biochem Biophys Res Commun; 2016 Jan; 469(3):565-72. PubMed ID: 26692493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of HHV-8 positive primary effusion lymphoma reveals pathogenetic and histogenetic features of the disease.
    Gaidano G; Capello D; Fassone L; Gloghini A; Cilia AM; Ariatti C; Buonaiuto D; Vivenza D; Gallicchio M; Avanzi GC; Prat M; Carbone A
    J Clin Virol; 2000 May; 16(3):215-24. PubMed ID: 10738140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting HGF/c-MET induces cell cycle arrest, DNA damage, and apoptosis for primary effusion lymphoma.
    Dai L; Trillo-Tinoco J; Cao Y; Bonstaff K; Doyle L; Del Valle L; Whitby D; Parsons C; Reiss K; Zabaleta J; Qin Z
    Blood; 2015 Dec; 126(26):2821-31. PubMed ID: 26531163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic analysis of a xenograft mice model for KSHV+ primary effusion lymphoma (PEL).
    Dai L; Trillo-Tinoco J; Bai L; Kang B; Xu Z; Wen X; Del Valle L; Qin Z
    PLoS One; 2014; 9(2):e90349. PubMed ID: 24587336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tyrosine kinase receptor met and its ligand HGF are co-expressed and functionally active in HHV-8 positive primary effusion lymphoma.
    Capello D; Gaidano G; Gallicchio M; Gloghini A; Medico E; Vivenza D; Buonaiuto D; Fassone L; Avanzi GC; Saglio G; Prat M; Carbone A
    Leukemia; 2000 Feb; 14(2):285-91. PubMed ID: 10673746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines.
    Gottwein E; Corcoran DL; Mukherjee N; Skalsky RL; Hafner M; Nusbaum JD; Shamulailatpam P; Love CL; Dave SS; Tuschl T; Ohler U; Cullen BR
    Cell Host Microbe; 2011 Nov; 10(5):515-26. PubMed ID: 22100165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for a Mesothelial Origin of Body Cavity Effusion Lymphomas.
    Sanchez-Martin D; Uldrick TS; Kwak H; Ohnuki H; Polizzotto MN; Annunziata CM; Raffeld M; Wyvill KM; Aleman K; Wang V; Marshall VA; Whitby D; Yarchoan R; Tosato G
    J Natl Cancer Inst; 2017 Sep; 109(9):. PubMed ID: 28376153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.